Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
Background: Cenobamate is an antiseizure medication used to treat partial-onset (focal) seizures. It is a molecule with one chiral center and a unique dual mechanism of action: enhancement of fast and slow inactivation of sodium channels with preferential inhibition of the persistent current and pos...
Main Authors: | Susan M. Melnick, Yujin Shin, Kelli J. Glenn |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023061285 |
Similar Items
-
Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
by: Jamir Pitton Rissardo, et al.
Published: (2023-07-01) -
Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABA<sub>A</sub> Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications
by: Dustin R. Latimer, et al.
Published: (2021-06-01) -
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
by: Vicente Villanueva, et al.
Published: (2023-09-01) -
Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
by: Zaccara G, et al.
Published: (2021-11-01) -
New evidence in adjunctive treatment of focal-onset seizures in adults: a critical appraisal
by: Simona Alfiere Lattanzi
Published: (2022-06-01)